Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
BBIO
BBIO News & Events
-
Add to Watchlist
Trade BBIO Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
BBIO News
Wall Street's Latest Ratings Overview
6d ago
CNBC
BridgeBio Pharma's BBP-418 Receives FDA Priority Review
May 27 2026
seekingalpha
BridgeBio's BBP-418 Receives FDA Priority Review for LGMD2I/R9
May 27 2026
Newsfilter
BridgeBio Pharma Shares Drop After Downgrade by Raymond James
May 26 2026
seekingalpha
Cardiovascular Disease Costs Set to Skyrocket, Urgent Need for AI Solutions
May 12 2026
PRnewswire
Cardiovascular Disease Costs Surge, AI Technology Becomes Key
May 12 2026
Newsfilter
BridgeBio's Encaleret Shows Promising Phase 3 Results for ADH1
May 12 2026
Newsfilter
BridgeBio Reports New Data on Acoramidis Efficacy
May 11 2026
NASDAQ.COM
Show More News
BBIO Events
No data
BBIO Monitor News
BridgeBio's Encaleret Phase 3 Results Show Significant Promise
May 15 2026
BridgeBio's Encaleret Phase 3 Results Boost Stock
May 13 2026
BridgeBio Pharma Reports Strong Q1 2026 Earnings and $500M Buyback
May 11 2026
BridgeBio Pharma's Awareness Campaign Boosts Stock Amid Market Decline
Apr 28 2026
BridgeBio Pharma's Shares Rise on Positive Patent Settlement News
Apr 27 2026
BridgeBio Submits NDA for BBP-418, Targeting LGMD2I/R9
Mar 31 2026
BridgeBio Pharma presents promising interim data for BBP-418
Mar 10 2026
BridgeBio Pharma Reports Strong Revenue Growth Amid Earnings Miss
Feb 25 2026
Show More Monitor News
BBIO Earnings Analysis
No Data
People Also Watch
